The Nonmelanoma Skin Cancer market is expected to experience substantial growth from 2024 to 2034, driven by increasing ...

More than half the patients with advanced and inoperable skin cancer ... activation can lead to cancer have yet to be unpicked. “Understanding of hedgehog mitogenic signaling is still developing ...

Findings from a phase 1 trial demonstrate that silmitasertib shows potential for the treatment of patients with advanced ...

We have also conducted an immunohistochemical study for expression of PTCH1 and SMO in a large panel of normal, ductal carcinomas in situ (DCIS), and invasive breast cancer (IBC ... these data suggest ...

The Hedgehog (Hh) pathway plays central roles in animal development and stem-cell function. Defects in Hh signalling lead to birth defects and cancer in humans. The first and often genetically ...